We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+8.8%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$46.2B
AUM Growth
+$1.83B
(+4.1%)
Cap. Flow
-$543M
Cap. Flow
% of AUM
-1.17%
Top 10 Holdings %
Top 10 Hldgs %
24.86%
Holding
1,809
New
24
Increased
1,140
Reduced
325
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$98M |
| 2 |
Kinder Morgan
KMI
|
+$97.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$96.6M |
| 4 |
UnitedHealth
UNH
|
+$77.5M |
| 5 |
Marriott International
MAR
|
+$58.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRC
First Republic Bank
FRC
|
+$198M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$179M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$162M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$154M |
| 5 |
Bank of America
BAC
|
+$112M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.89% |
| 2 | Healthcare | 18.49% |
| 3 | Financials | 11.85% |
| 4 | Consumer Discretionary | 9.1% |
| 5 | Industrials | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Steel Dynamics
STLD
$37.5B
| $21.1M | 0.05% |
186,409
-15,268
| -8% | -$1.77M |
|
277
Ingersoll Rand
IR
$33.9B
| $21M | 0.05% |
361,183
-124,136
| -26% | -$7M |
|
278
DoorDash
DASH
$85.2B
| $21M | 0.05% |
329,861
+29,450
| +10% | +$1.69M |
|
279
Weyerhaeuser
WY
$17.7B
| $20.6M | 0.04% |
684,350
-244,432
| -26% | -$7.71M |
|
280
KLA
KLAC
$249B
| $20.1M | 0.04% |
504,750
+48,030
| +11% | +$1.89M |
|
281
HP
HPQ
$25.9B
| $20M | 0.04% |
680,298
-86,468
| -11% | -$2.48M |
|
282
FirstEnergy
FE
$28.7B
| $19.9M | 0.04% |
495,578
-103,077
| -17% | -$4.16M |
|
283
Northern Trust
NTRS
$22.2B
| $19.8M | 0.04% |
224,816
-190,883
| -46% | -$17.7M |
|
284
McCormick & Company Non-Voting
MKC
$13.9B
| $19.7M | 0.04% |
236,884
+16,698
| +8% | +$1.27M |
|
285
Elanco Animal Health
ELAN
$12.7B
| $19.5M | 0.04% |
2,072,095
+1,929,895
| +1,357% | +$22.8M |
|
286
CF Industries
CF
$18.9B
| $19.4M | 0.04% |
267,704
+17,710
| +7% | +$1.45M |
|
287
General Dynamics
GD
$106B
| $19.4M | 0.04% |
84,891
-8,507
| -9% | -$1.97M |
|
288
Edwards Lifesciences
EW
$48.2B
| $19.1M | 0.04% |
230,854
-93,366
| -29% | -$7.34M |
|
|
RXDX
289
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $19M | 0.04% |
177,457
+8,250
| +5% | +$950K |
|
290
Lennar Class A
LEN
$21.1B
| $19M | 0.04% |
187,155
| – | – |
|
291
Synchrony
SYF
$25.1B
| $19M | 0.04% |
651,726
+31,414
| +5% | +$1.06M |
|
292
Transocean
RIG
$5.52B
| $18.9M | 0.04% |
+2,976,944
| New | +$19.1M |
|
293
Evergy
EVRG
$19.7B
| $18.9M | 0.04% |
309,416
-44,810
| -13% | -$2.73M |
|
294
Bunge Global
BG
$22.8B
| $18.8M | 0.04% |
196,564
+930
| +0.5% | +$90.4K |
|
295
Builders FirstSource
BLDR
$7.93B
| $18.7M | 0.04% |
210,330
-64,936
| -24% | -$5.14M |
|
296
DTE Energy
DTE
$30.4B
| $18.4M | 0.04% |
168,200
+43,554
| +35% | +$4.88M |
|
297
BridgeBio Pharma
BBIO
$16.8B
| $17.9M | 0.04% |
1,080,259
+256,300
| +31% | +$2.99M |
|
298
Atlassian
TEAM
$25.4B
| $17.8M | 0.04% |
103,934
+13,435
| +15% | +$2.14M |
|
299
Expeditors International
EXPD
$22.4B
| $17.6M | 0.04% |
159,727
-10,125
| -6% | -$1.1M |
|
300
US Physical Therapy
USPH
$1.2B
| $17.5M | 0.04% |
178,701
+15,168
| +9% | +$1.45M |
|
Similar funds
SCP
Ensign Peak Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, Ensign Peak Advisors held 1,809 positions worth $46.2B, up 4.1% from $44.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 3.4%. Ensign Peak Advisors opened 24 new positions and exited 37, leaving the 1,809-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q1 2023 buy was State Street Financial Select Sector SPDR ETF: 1,117,296 shares worth $35.9M.
- Ensign Peak Advisors added most to Eli Lilly in Q1 2023, an estimated $98M increase.
- Ensign Peak Advisors's biggest Q1 2023 reduction was First Republic Bank, cutting an estimated $198M.
- Ensign Peak Advisors fully exited iShares Russell 2000 ETF in Q1 2023, selling an estimated $179M.
- Ensign Peak Advisors's ten largest holdings make up 25% of its $46.2B portfolio in Q1 2023.
- Ensign Peak Advisors opened 24 new positions and closed 37 in Q1 2023.
- Ensign Peak Advisors's portfolio value rose 4.1% quarter-over-quarter to $46.2B.
Based on Ensign Peak Advisors's 13F filing for Q1 2023, filed 15 May 2023.